Yale Recruiting for Topical Tofacitinib Alopecia Areata Trials

Posted by Mike Peake

In this article: Hair Loss | Alopecia

Researchers at Yale University in America are recruiting people with Alopecia Areata the autoimmune disorder that leads to patchy hair loss for a further study into the use of a drug which has already shown itself to be very promising.

Having already seen impressive regrowth in one-third of the patients who took a JAK inhibitor drug named tofacitinib orally, the team at Yale now want to see if they have better results with a topical version of tofacitinib, specifically, an ointment to be rubbed into the scalp. Topical application could also potentially mean a decreased risk of serious side-effects.

dr-brett-king-yale-universityPioneering research

The study is being led by Dr Brett King, a name frequently associated of late with some of the most pioneering research into new treatments for Alopecia Areata and its related conditions.

Copy of New Street Ground Floor Reception 1 no pink nail polish

The Belgravia Centre

The Belgravia Centre is a world-renowned group of a hair loss clinic in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation from anywhere in the world for home-use treatment.

View our Hair Loss Success Stories, which includes the world's largest gallery of hair growth photos and demonstrates the level of success that so many of Belgravia's patients achieve.

Posted by Mike Peake

In this article: Hair Loss | Alopecia

Related posts